Atrovent and cognitive deterioration 
Atrovent and cognitive deterioration Patient Reports February 12, 2012
Atrovent Side Effects Report #4815435-2
Atrovent side effect was reported by a Health Professional from on Oct 21, 2005. Male patient, weighting 551.2 lb, was diagnosed with chronic obstructive pulmonary disease, epilepsy
and was treated with Atrovent. After drug was administered, patient experienced the following side effects: cognitive deterioration, dementia . Atrovent dosage: 0,4 MG/ML. During the same period patient was treated with FENITOINE, DIPHENILHIDANTOINE. Patient recovered.Atrovent Side Effects Report #4830868-6
Atrovent side effect was reported by a Health Professional from on Oct 21, 2005. Male patient, weighting 551.2 lb, was diagnosed with chronic obstructive pulmonary disease, epilepsy
and was treated with Atrovent. After drug was administered, patient experienced the following side effects: cognitive deterioration, dementia . Atrovent dosage: 0,4 MG/ML. During the same period patient was treated with FENITOINE, DIPHENILHIDANTOINE. Patient recovered.Atrovent Side Effects Report #4836129-3
Atrovent side effect was reported by a Health Professional from on Oct 21, 2005. Male patient, weighting 110.2 lb, was diagnosed with chronic obstructive pulmonary disease, epilepsy
, respiratory tract infection and was treated with Atrovent. After drug was administered, patient experienced the following side effects: cognitive deterioration, confusional state, delirium, disorientation, dyspepsia, dysphoria, insomnia, neuralgia. Atrovent dosage: 0,4 MG/ML. During the same period patient was treated with FENITOINE, DIPHENILHIDANTOINE, ACETYLCYSTEINE, BUDENOSIDE, SALBUTAMOL, VITAMINS, OMEPRAZOLE, BROMEXINE. Patient recovered.Atrovent Side Effects Report #4872564-5
Atrovent side effect was reported by a Health Professional from on Oct 21, 2005. Male patient, weighting 110.2 lb, was diagnosed with chronic obstructive pulmonary disease, epilepsy
, respiratory tract infection and was treated with Atrovent. After drug was administered, patient experienced the following side effects: cerebrovascular accident, chronic obstructive pulmonary disease, cognitive deterioration, confusional state, convulsion, cough, delirium, dementia , dyspepsia. Atrovent dosage: 0,4 MG/ML. During the same period patient was treated with FENITOINE, DIPHENILHIDANTOINE, ACETYLCYSTEINE, BUDENOSIDE, SALBUTAMOL, VITAMINS, OMEPRAZOLE, BROMEXINE. Patient recovered.Atrovent Side Effects Report #4884460-8
Atrovent side effect was reported by a Health Professional from on Oct 21, 2005. Male patient, weighting 110.2 lb, was diagnosed with chronic obstructive pulmonary disease, epilepsy
, respiratory tract infection and was treated with Atrovent. After drug was administered, patient experienced the following side effects: cognitive deterioration, confusional state, delirium, dyspepsia, dysphoria, insomnia. Atrovent dosage: 0,4 MG/ML. During the same period patient was treated with FENITOINE, DIPHENILHIDANTOINE, ACETYLCYSTEINE, BUDENOSIDE, SALBUTAMOL, VITAMINS, OMEPRAZOLE, BROMEXINE. Patient recovered.Atrovent Side Effects Report #4887370-5
Atrovent side effect was reported by a Health Professional from on Oct 21, 2005. Male patient, weighting 110.2 lb, was diagnosed with chronic obstructive pulmonary disease, epilepsy
, respiratory tract infection and was treated with Atrovent. After drug was administered, patient experienced the following side effects: cognitive deterioration, confusional state, delirium, dysphoria, insomnia, respiratory tract infection. Atrovent dosage: 0,4 MG/ML. During the same period patient was treated with FENITOINE, DIPHENILHIDANTOINE, ACETYLCYSTEINE, BUDENOSIDE, SALBUTAMOL, VITAMINS, OMEPRAZOLE, BROMEXINE. Patient recovered.